Mark Borns, Pharmd

Mark Borns, Pharmd Email and Phone Number

Director, Medical Value Liaisons @ Apellis Pharmaceuticals
Mark Borns, Pharmd's Location
Charlotte, North Carolina, United States, United States
Mark Borns, Pharmd's Contact Details

Mark Borns, Pharmd work email

Mark Borns, Pharmd personal email

n/a

Mark Borns, Pharmd phone numbers

About Mark Borns, Pharmd

Experienced pharmaceutical professional with a core focus on payers, formulary decision makers, access, and reimbursement. Leader with a demonstrated history of working across multiple roles in the industry. Skills include US national payer engagement, US brand launch, new product planning, and global market access strategy. Therapeutic experience in ophthalmology, immunology, diabetes, obesity, neuroscience, oncology, and rare disease.

Mark Borns, Pharmd's Current Company Details
Apellis Pharmaceuticals

Apellis Pharmaceuticals

View
Director, Medical Value Liaisons
Mark Borns, Pharmd Work Experience Details
  • Apellis Pharmaceuticals
    Director, Medical Value Liaisons
    Apellis Pharmaceuticals Oct 2024 - Present
    Waltham, Ma, Us
  • Apellis Pharmaceuticals
    Medical Value Liaison
    Apellis Pharmaceuticals Mar 2022 - Oct 2024
    Waltham, Ma, Us
    Focus on national US payers and high priority regional payers to deliver clinical and HEOR information for the full Apellis portfolio including rare disease and ophthalmology. Enable research collaborations to communicate and translate data into evidence supporting pharmacoeconomics, health outcomes, formulary management, and health policy. Collaborate with commercial and health outcomes partners to build and maintain strong customer relationships and act as the point of contact for clinical and medical requests.
  • Eli Lilly And Company
    Therapeutic Leader Evidence And Outcomes: Immunology
    Eli Lilly And Company Dec 2021 - Feb 2022
    Indianapolis, Indiana, Us
    Guide the Outcomes Liaison capability with business partners to advance performance and capabilitiesLead launch preparation and execution for new molecules or indications and influence research plans to maximize utility for payers Serve as a peer expert for Outcomes Liaison colleagues in order to optimally meet customer needs and provide excellent customer experiences
  • Eli Lilly And Company
    Evidence And Outcomes Liaison
    Eli Lilly And Company Nov 2019 - Dec 2021
    Indianapolis, Indiana, Us
    Engage with payer customers and population health decision makers in the Southeast to deliver value-based medical information.Demonstrate expertise across autoimmune, neuroscience, and diabetes therapeutic classes, and utilize available research to communicate and translate data into evidence supporting pharmacoeconomics, health outcomes, formulary management, and health policy. Collaborate with commercial and health outcomes partners to build positive customer experiences, develop relationships, and act as the point of contact for value and population health decision makers.
  • Eli Lilly And Company
    Assoc. Director: Us Payer Marketing - Olumiant
    Eli Lilly And Company Oct 2018 - Nov 2019
    Indianapolis, Indiana, Us
    Lead US commercial market access and contracting strategy for Olumiant (barcitinib) in rheumatoid arthritis to grow JAKi class against competitive challenges around existing TNFi statuses. Refine payer value proposition messages and support key account managers in RA and autoimmune formulary decision making considerations.Execute access realization of account contracts through payer marketing strategy and analytical targeting that drives share of market.
  • Eli Lilly And Company
    Accoc. Director: Global Price, Reimbursement And Access: New Product Planning - Diabetes
    Eli Lilly And Company Jun 2017 - Sep 2018
    Indianapolis, Indiana, Us
    Lead global price, reimbursement, and access recommendations on phase 3 commercial decision of tirzepatide (GIP/GLP-1). This included work with marketing, market research, forecasting, and affiliate partners.Prepare commercial considerations on market access and pricing into early phase work evaluating indications in type 2 diabetes mellitus, chronic heart failure, NASH, dyslipidemia, weight loss, and kidney disease. Drive quality payer customer feedback into early-phase product planning by participation in advisory boards and market research in the US and OUS markets focused on early phase diabetes, cardiovascular and renal development. Shape the development of pipeline molecules including price, reimbursement, access, medical and health outcomes for input to commercial strategy.Deliver consistent and appropriate recommendations into forecasting that support business decision making for early phase molecules and ultimately phase III development.
  • Eli Lilly And Company
    Global Pricing, Reimbursement And Access: New Product Planning - Visiting Scientist Fellow
    Eli Lilly And Company Jun 2016 - Jun 2017
    Indianapolis, Indiana, Us
    Post doctoral fellowship focused on special projects across all therapeutic areas. Emphasis in oncology, price and access evaluation of immuno-oncology PD-L(1) agents, global market access environmental trends, and the influence of direct (head-to-head) comparator data on US commercial success.
  • Sinfoniarx
    Intern
    Sinfoniarx Sep 2014 - May 2016
    Assisted patients in formulary conversions, performed comprehensive medication reviews (CMRs) and when clinically appropriate, worked directly with patients and prescribers to tailor optimal medication regimens.
  • Walgreens
    Pharmacy Intern
    Walgreens Aug 2013 - Sep 2014
    Deerfield, Il, Us
  • Discount Drug Mart
    Pharmacy Technician/Intern
    Discount Drug Mart Apr 2010 - Aug 2013
    Medina, Ohio, Us

Mark Borns, Pharmd Skills

Pharmacy Leadership Patient Counseling Medication Therapy Management Certified Immunizer Pharmacists Immunization Compounding Pharmacy Automation Community Pharmacy Healthcare Prescription Pharmacy Practice

Mark Borns, Pharmd Education Details

  • The Ohio State University
    The Ohio State University
    Doctor Of Pharmacy (Pharmd)
  • The Ohio State University
    The Ohio State University
    Pharmaceutical Sciences

Frequently Asked Questions about Mark Borns, Pharmd

What company does Mark Borns, Pharmd work for?

Mark Borns, Pharmd works for Apellis Pharmaceuticals

What is Mark Borns, Pharmd's role at the current company?

Mark Borns, Pharmd's current role is Director, Medical Value Liaisons.

What is Mark Borns, Pharmd's email address?

Mark Borns, Pharmd's email address is bo****@****osu.edu

What is Mark Borns, Pharmd's direct phone number?

Mark Borns, Pharmd's direct phone number is +193790*****

What schools did Mark Borns, Pharmd attend?

Mark Borns, Pharmd attended The Ohio State University, The Ohio State University.

What skills is Mark Borns, Pharmd known for?

Mark Borns, Pharmd has skills like Pharmacy, Leadership, Patient Counseling, Medication Therapy Management, Certified Immunizer, Pharmacists, Immunization, Compounding, Pharmacy Automation, Community Pharmacy, Healthcare, Prescription.

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Download 750 million emails and 100 million phone numbers

Access emails and phone numbers of over 750 million business users. Instantly download verified profiles using 20+ filters, including location, job title, company, function, and industry.